Actigraphy Devices Market Report 2026

Actigraphy Devices Market Overview

• Actigraphy Devices market size has reached to $2.59 billion in 2025 • Expected to grow to $3.9 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Rise In Sleep Disorders Fueling The Growth Of The Market Due To Increasing Screen Time Disrupting Circadian Rhythms • Market Trend: Advancements In Multisensor Wearable Devices For Continuous Health Monitoring • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Actigraphy Devices Market?

Actigraphy devices are non-invasive wearable tools designed to monitor and record physical activity and rest patterns over extended periods. The primary purpose of actigraphy devices is to monitor and assess sleep-wake patterns and physical activity levels by tracking movement, helping diagnose sleep disorders and evaluate circadian rhythm disturbances. The main products of actigraphy devices include wearable actigraphy devices and handheld actigraphy devices. Wearable actigraphy devices are small, lightweight sensors designed to be worn on the wrist, ankle, or clipped onto clothing. It is distributed through online and brick-and-mortar and is applied for sleep disorders monitoring, circadian rhythm disorder monitoring, insomnia and restless leg syndrome diagnosis, and others. It is used for various end uses, such as healthcare providers, research institutions, home care settings, and fitness and sports centers.

What Is The Actigraphy Devices Market Growth Forecast?

The actigraphy devices market size is expected to see strong growth in the next few years. It will grow to $3.9 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising integration of actigraphy in digital health platforms, expansion of personalized sleep therapy solutions, growing use of actigraphy in clinical trials, increasing focus on preventive sleep health management. Major trends in the forecast period include increasing adoption of wearable sleep monitoring devices, rising integration of actigraphy with mobile health apps, growing demand for long-term sleep tracking solutions, expansion of clinical and home-based monitoring use, enhanced focus on data accuracy and patient compliance.

What Is The Driver Of The Actigraphy Devices Market?

The increasing prevalence of sleep disorders is projected to fuel the growth of the actigraphy devices market in the coming years. Sleep disorders are conditions that disrupt the quality, timing, or duration of sleep, affecting overall health and daily functioning. Sleep disorders are rising due to increasing screen time, which disrupts the body's natural circadian rhythm by suppressing melatonin production through prolonged exposure to blue light. Actigraphy devices are required for sleep disorders as they enable continuous, non-invasive monitoring of sleep-wake patterns over extended periods, providing objective data to support accurate assessment and treatment planning. For instance, in November 2023, according to the National Health Service, a UK-based publicly funded healthcare system, 37.8% of kids between the ages of 8 and 16 reported having sleep issues at least three times in the previous seven days. Sleep problems affected 76.5% of people with likely mental disorders and 25.0% of people without them. Therefore, the increasing prevalence of sleep disorders will drive the growth of the actigraphy devices industry.

Key Players In The Global Actigraphy Devices Market

Major companies operating in the actigraphy devices market are Koninklijke Philips N.V., ResMed Inc., Nox Health, VIVISOL SRL, Compumedics Limited, Empatica Inc., Cidelec, Cleveland Medical Devices Inc., Advanced Brain Monitoring Inc., CAMNTECH Limited, ActivInsights Ltd., Mini Mitter Co., Condor Instruments, SOMNOmedics GmbH, Itamar Medical Ltd., Neurosoft Ltd., BioSerenity, ActiGraph LLC, Philips Respironics, SleepScore Labs

Global Actigraphy Devices Market Trends and Insights

Major companies operating in the actigraphy devices market are focusing on developing technologically advanced products, such as multisensor wearable devices, to enable continuous and hands-free monitoring. Multisensor wearable devices are advanced wearables equipped with multiple integrated sensors that simultaneously monitor various physiological and environmental parameters such as movement, heart rate, temperature, and sleep patterns. For instance, in November 2023, ActiGraph LLC, a US-based digital health company, launched the ActiGraph LEAP, a multisensor wearable. The ActiGraph LEAP features a comprehensive collection of sensors, enabling continuous digital monitoring of physical activity, sleep, mobility, and vital signs all within a single device. Designed to meet the evolving demands of treatment effectiveness demonstrations, it sets a new standard for patient-centered digital measurement collection. The device’s six integrated sensors capture over 25 distinct digital health measures, including heart rate, oxygen saturation, blood pressure, and skin temperature, alongside activity, sleep, and gait data. Data is seamlessly uploaded to the CentrePoint platform, where it is processed using advanced, validated algorithms to provide accurate insights.

What Are Latest Mergers And Acquisitions In The Actigraphy Devices Market?

In February 2024, Cambridge Cognition Holdings plc, a UK-based developer and marketer of digital brain-health assessment solutions, entered into a strategic partnership with ActiGraph. Through this partnership, the companies aim to combine Cambridge Cognition’s validated digital cognitive and speech assessments with ActiGraph’s actigraphy-based wearables and Accelerant digital health technology platform to accelerate the adoption of multi-modal digital measurements in central nervous system trials, enabling a more comprehensive view of patients’ mental and physical capabilities and improving the sensitivity and efficiency of CNS drug development within the actigraphy devices market. ActiGraph is a US-based provider of medical-grade actigraphy wearables and digital health technology solutions for clinical research.

What Defines the Actigraphy Devices Market?

The actigraphy devices market consists of sales of sleep monitoring systems, charging docks and cables, calibration tools, carrying cases and protective covers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Actigraphy Devices Market Report 2026?

The actigraphy devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the actigraphy devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.